@joshua/acute-stroke-and-seizures

Acute stroke and seizures

Author-made · not reviewedNeurologyCC BY 4.0

Written by the BenchClub team with AI help. Answers follow public guidelines and textbooks; not yet reviewed by a practising physician.

v128 questionsUpdated Nov 17, 2026

Run it
  1. SE-001Multiple choiceNeurologyIntermediate

    A 29-year-old woman has taken a combined oral contraceptive for 1 year. She has had a headache for 5 days and today had a generalized tonic-clonic seizure followed by right-sided weakness. CT shows a left frontoparietal subcortical hemorrhage with surrounding edema; CT venography shows thrombosis of the superior sagittal sinus and left transverse sinus. What is the most appropriate initial antithrombotic treatment?

    1. AAnticoagulation is contraindicated because of the intracranial hemorrhage; supportive care only
    2. BAspirin 81 mg daily
    3. CImmediate systemic IV alteplase
    4. DObserve for 2 weeks and anticoagulate once repeat CT shows the hemorrhage has resolved
    5. ETherapeutic-dose low-molecular-weight heparin (or unfractionated heparin) and stop the oral contraceptive
    Show answer

    Answer E

    Source 2017 ESO Guideline for the diagnosis and treatment of cerebral venous thrombosis; 2024 AHA Scientific Statement on the diagnosis and management of cerebral venous thrombosis

  2. SE-002Multiple choiceNeurologyIntermediate

    A 71-year-old woman presents 2 hours after sudden left hemiparesis. NIHSS 9, CT shows no hemorrhage, and she has no other contraindication to thrombolysis. BP is 196/112 mmHg and the same on repeat measurement. What is the best next step?

    1. ABP is above 185/110 mmHg, so IV thrombolysis is no longer an option
    2. BGive sublingual nifedipine and start thrombolysis immediately
    3. CStart thrombolysis and lower the BP during the infusion
    4. DLower the BP with IV labetalol, nicardipine or clevidipine to below 185/110 mmHg and give thrombolysis once it is maintained below that level
    5. ELower the BP to below 140/90 mmHg before giving thrombolysis
    Show answer

    Answer D

    Source 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke (BP management before IV thrombolysis)

  3. SE-003Multiple choiceNeurologyAdvanced

    A 67-year-old man woke at 6 AM with right-sided weakness and word-finding difficulty; he was normal when he went to bed at 10 PM. He arrives at 8 AM with NIHSS 7. Brain MRI shows a small area of DWI hyperintensity in the left frontal lobe (less than one-third of the MCA territory) with no corresponding FLAIR signal change; MRA shows no large-vessel occlusion. He takes no anticoagulants, BP and glucose are normal, and there is no other contraindication to thrombolysis. What is the most appropriate management?

    1. AHe was last known well 10 hours ago, outside the window; give aspirin only
    2. BIV alteplase
    3. CEmergency endovascular thrombectomy
    4. DAspirin plus clopidogrel; no thrombolysis
    5. EObtain CT perfusion first and do nothing if there is no mismatch
    Show answer

    Answer B

    Source 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke (IV thrombolysis in unknown-onset stroke with MRI DWI-FLAIR mismatch); WAKE-UP trial (NEJM 2018)

  4. SE-004Multiple choiceNeurologyAdvanced

    A 68-year-old man who was fully independent before (mRS 0) was last known well 9 hours ago. NIHSS 18. CT: ASPECTS 4, no significant mass effect or midline shift; CTA shows occlusion of the right MCA M1 segment. Per the 2026 AHA/ASA guideline, what is the most appropriate management?

    1. AASPECTS below 6 means the core is too large; thrombectomy is not indicated
    2. BEmergency endovascular thrombectomy
    3. CImmediate decompressive hemicraniectomy
    4. DIV alteplase
    5. EThrombectomy only if CT perfusion shows a mismatch ratio above 1.8
    Show answer

    Answer B

    Source 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke (large-core thrombectomy: SELECT2, ANGEL-ASPECT, RESCUE-Japan LIMIT)

  5. SE-005Multiple choiceNeurologyAdvanced

    A 76-year-old man with AF, independent before the stroke (mRS 0), takes apixaban 5 mg twice daily; his last dose was 8 hours ago. He presents 2 hours after sudden aphasia and right hemiparesis, NIHSS 15. CT shows no hemorrhage (ASPECTS 9); CTA shows a left MCA M1 occlusion. INR 1.1 and aPTT are normal; the hospital cannot measure anti-Xa activity. Thrombectomy is available on site. What is the most appropriate management?

    1. AINR and aPTT are normal, so give IV alteplase
    2. BReverse with IV idarucizumab, then give IV thrombolysis
    3. CProceed directly to endovascular thrombectomy without IV thrombolysis
    4. DGive reduced-dose tenecteplase 0.1 mg/kg
    5. ENo reperfusion therapy because he is anticoagulated
    Show answer

    Answer C

    Source 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke (recent DOAC intake and IV thrombolysis; thrombectomy-eligible patients); 2019 AHA/ASA Guidelines (IV thrombolysis within 48 hours of a factor Xa inhibitor not recommended unless specific assays are normal)

  6. SE-006Multiple choiceNeurologyIntermediate

    A 59-year-old man has had numbness and mild clumsiness of the right hand for 3 hours. NIHSS 2; the deficit does not interfere with his daily activities. CT shows no hemorrhage, CTA shows no large-vessel occlusion, ECG shows sinus rhythm, and he has no bleeding tendency. Which management is most appropriate?

    1. AIV alteplase
    2. BAspirin 81 mg daily alone
    3. CRivaroxaban 20 mg daily
    4. DAspirin plus clopidogrel for 1 year
    5. EAspirin plus clopidogrel (with a loading dose) for 21 days, then a single antiplatelet agent
    Show answer

    Answer E

    Source 2021 AHA/ASA Guideline for the Prevention of Stroke in Patients With Stroke and TIA (CHANCE, POINT); 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke (minor nondisabling stroke: PRISMS, ARAMIS)

  7. SE-008Multiple choiceNeurologyIntermediate

    A 58-year-old man presents 2 hours after sudden left-sided weakness. GCS 14; CT shows a right basal ganglia hematoma of about 15 mL without intraventricular extension. BP 202/110 mmHg. What is the most appropriate BP target?

    1. ALower smoothly to a systolic BP of about 140 mmHg within 1 hour and keep it at 130-150 mmHg
    2. BLower the systolic BP below 110 mmHg as fast as possible to prevent hematoma expansion
    3. CDo not treat while systolic BP is below 220 mmHg, to preserve cerebral perfusion
    4. DSublingual nifedipine to reach 120/80 mmHg within 30 minutes
    5. ELower gradually by 15% over 24 hours without a specific target
    Show answer

    Answer A

    Source 2022 AHA/ASA Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage

  8. SE-009Multiple choiceNeurologyBasic

    A 74-year-old woman with a mechanical valve on long-term warfarin developed a sudden headache and right hemiparesis 1 hour ago. CT shows a left thalamic hemorrhage; INR 2.8. What is the preferred reversal strategy?

    1. AFresh frozen plasma 2 units alone
    2. BProtamine 50 mg IV
    3. COral vitamin K 2.5 mg
    4. DIdarucizumab 5 g IV
    5. EFour-factor prothrombin complex concentrate (4F-PCC) plus IV vitamin K 10 mg
    Show answer

    Answer E

    Source 2022 AHA/ASA Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage (reversal of vitamin K antagonists)

  9. SE-010Multiple choiceNeurologyAdvanced

    A 66-year-old man with hypertension has had vertigo, vomiting and gait instability for 3 hours. GCS is 14 on arrival and falls to 11 two hours later. CT: right cerebellar hematoma, maximum diameter about 3.5 cm (about 20 mL), with compression of the fourth ventricle and dilated lateral and third ventricles. He takes no anticoagulant or antiplatelet drugs, and coagulation studies are normal. What is the most appropriate management?

    1. AMannitol and conservative observation
    2. BExternal ventricular drain alone
    3. CImmediate surgical evacuation of the hematoma (with or without an external ventricular drain)
    4. DLumbar puncture to lower intracranial pressure
    5. EIV tranexamic acid and observe the hematoma
    Show answer

    Answer C

    Source 2022 AHA/ASA Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage (cerebellar ICH)

  10. SE-012Multiple choiceNeurologyIntermediate

    A 42-year-old woman has an acute right parietal cortical infarct. She has no hypertension, diabetes or smoking history. Workup: normal cervical and intracranial vessels; TEE shows a patent foramen ovale with an atrial septal aneurysm and a large right-to-left shunt; 72-hour ambulatory monitoring shows no AF; thrombophilia screen negative. Which secondary prevention is most appropriate?

    1. ALifelong warfarin
    2. BLifelong aspirin plus clopidogrel
    3. COpen surgical PFO repair
    4. DNo specific treatment
    5. ETranscatheter PFO closure plus long-term antiplatelet therapy
    Show answer

    Answer E

    Source 2021 AHA/ASA Guideline for the Prevention of Stroke in Patients With Stroke and TIA (PFO closure); 2020 AAN Practice Advisory update on PFO and secondary stroke prevention

  11. SE-013Multiple choiceNeurologyAdvanced

    A 63-year-old man underwent thrombectomy 4 hours after onset for a left MCA M1 occlusion, with complete recanalization (mTICI 3); he did not receive IV thrombolysis and has no heart failure, aortic dissection or other condition requiring strict BP control. Back on the stroke unit his BP is 168/92 mmHg. Per the 2026 AHA/ASA guideline, what is the most appropriate BP management in the first 24 hours after the procedure?

    1. AIntensive lowering to a systolic target below 120 mmHg
    2. BSystolic target below 140 mmHg for 72 hours
    3. CMaintain BP ≤180/105 mmHg
    4. DNo BP monitoring or control is needed after complete recanalization
    5. EPermissive hypertension up to 220/120 mmHg, as for patients who receive no reperfusion therapy
    Show answer

    Answer C

    Source 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke (intensive SBP lowering below 140 mmHg after successful thrombectomy is harmful); OPTIMAL-BP (JAMA 2023); ENCHANTED2/MT (Lancet 2022); BEST-II (JAMA 2023, futility of lower targets)

  12. SE-014Multiple choiceNeurologyBasic

    A 61-year-old man has a left MCA territory infarct; CTA shows a 60% atherosclerotic stenosis of the left MCA M1 segment. LDL-C 124 mg/dL, normal liver function. Per the 2021 AHA/ASA secondary prevention guideline, which lipid therapy is correct?

    1. ALDL-C is in the normal range, so no lipid-lowering therapy is needed
    2. BDiet only, recheck in 3 months
    3. CModerate-intensity statin with an LDL-C goal below 100 mg/dL
    4. DHigh-intensity statin (adding ezetimibe if needed) with an LDL-C goal below 70 mg/dL
    5. EA fibrate as first-line therapy
    Show answer

    Answer D

    Source 2021 AHA/ASA Guideline for the Prevention of Stroke in Patients With Stroke and TIA (statin ± ezetimibe to LDL-C <70 mg/dL, Class 1; TST trial, NEJM 2020)

  13. SE-016Multiple choiceNeurologyIntermediate

    A 27-year-old woman (60 kg), 12 weeks pregnant, with known focal epilepsy, is in continuous focal to bilateral tonic-clonic (convulsive) seizure activity. She has received IV diazepam 10 mg twice and is still seizing about 15 minutes after onset. BP 128/76 mmHg, urine protein negative. What is the preferred next step?

    1. AValproate 40 mg/kg IV
    2. BA third dose of diazepam 10 mg IV
    3. CImmediate intubation and propofol anesthesia
    4. DPhenobarbital 30 mg orally
    5. ELevetiracetam 60 mg/kg (maximum 4500 mg) IV
    Show answer

    Answer E

    Source 2016 American Epilepsy Society Guideline: Treatment of Convulsive Status Epilepticus; ESETT trial (NEJM 2019); 2024 AAN/AES/SMFM practice guideline on teratogenesis and perinatal outcomes with antiseizure medications

  14. SE-017Multiple choiceNeurologyAdvanced

    A 45-year-old man (70 kg) is in convulsive status epilepticus. He has received two adequate doses of lorazepam, levetiracetam 60 mg/kg IV and valproate 40 mg/kg IV. It is now 55 minutes since onset; he continues to have recurrent tonic-clonic seizures without regaining consciousness between them. What is the most appropriate next step?

    1. AA ketamine bolus on the ward without airway control, then observe
    2. BA third dose of lorazepam 4 mg IV
    3. CTransfer to the ICU and obtain an EEG before giving any further treatment
    4. DIntubation and a continuous midazolam or propofol infusion titrated to continuous EEG
    5. ETopiramate via nasogastric tube and reassess in 24 hours
    Show answer

    Answer D

    Source 2012 Neurocritical Care Society Guideline for the Evaluation and Management of Status Epilepticus (refractory SE; expert consensus); 2016 American Epilepsy Society Guideline: Treatment of Convulsive Status Epilepticus; ESETT trial (Kapur et al., NEJM 2019)

  15. SE-018Multiple choiceNeurologyIntermediate

    A 19-year-old woman has had brief jerks of both arms in the mornings for a year, often flinging her toothbrush; a week ago, after staying up all night, she had a generalized tonic-clonic seizure. EEG: generalized 4-6 Hz polyspike-and-wave discharges provoked by photic stimulation. Juvenile myoclonic epilepsy is diagnosed. She has no plans for pregnancy but does not use contraception. What is the most appropriate initial medication?

    1. ALevetiracetam
    2. BCarbamazepine
    3. CValproate
    4. DOxcarbazepine
    5. EPhenytoin
    Show answer

    Answer A

    Source 2024 AAN/AES/SMFM practice guideline: teratogenesis, perinatal and neurodevelopmental outcomes after in utero exposure to antiseizure medication; NICE NG217 Epilepsies in children, young people and adults (2022); FDA valproate boxed warning (fetal risk)

  16. SE-020Multiple choiceNeurologyAdvanced

    A 52-year-old man with generalized epilepsy has been well controlled on valproate 500 mg twice daily. He is treated with meropenem 1 g every 8 hours for hospital-acquired pneumonia (susceptible non-carbapenem alternatives are available) and on day 3 has two generalized tonic-clonic seizures. His valproate level is below 10 mcg/mL (previously about 70 mcg/mL). What is the most appropriate management?

    1. AIncrease valproate to 1000 mg twice daily
    2. BAdd carbamazepine
    3. CStop all antiseizure medications and repeat the EEG
    4. DSwitch to a non-carbapenem antibiotic and add (or switch to) another antiseizure medication such as levetiracetam until valproate levels recover
    5. EContinue the current regimen and repeat the head CT
    Show answer

    Answer D

    Source Depakote (divalproex sodium) US prescribing information (interaction with carbapenems); Merrem (meropenem) US prescribing information

  17. SE-021Multiple choiceNeurologyIntermediate

    A 58-year-old man with convulsive status epilepticus stops convulsing after diazepam and levetiracetam. Forty minutes after the convulsions stopped he remains comatose (GCS 7). The last diazepam dose was 50 minutes ago, he is not on any continuous sedative or anesthetic infusion, vital signs are stable, glucose is normal, and he has occasional subtle nystagmoid eye movements. EEG can be started at the bedside immediately. What is the most important next step?

    1. AThis is a postictal state; observe for 24 hours
    2. BImmediate (continuous) EEG monitoring to look for nonconvulsive status epilepticus
    3. CUrgent contrast MRI and an EEG in 2 days
    4. DAdd haloperidol for sedation
    5. EEmpirically add a third antiseizure medication without an EEG
    Show answer

    Answer B

    Source 2012 Neurocritical Care Society Guideline for the Evaluation and Management of Status Epilepticus; 2015 ACNS consensus statement on continuous EEG monitoring in critically ill adults

  18. SE-022Short answerNeurologyIntermediate

    A 66-year-old woman (60 kg) arrives 1.5 hours after sudden left hemiparesis and rightward gaze deviation. NIHSS 14, BP 176/94 mmHg, glucose 130 mg/dL, not on anticoagulants. CT shows no hemorrhage; CTA shows a right MCA M1 occlusion, and the hospital can perform thrombectomy. Describe the management in the first hour after arrival and the precautions for the 24 hours after thrombolysis.

    Rubric

    • +3Gives IV thrombolysis immediately at the correct dose (alteplase 0.9 mg/kg or tenecteplase 0.25 mg/kg; 0.6 mg/kg earns no credit)
    • +3Proceeds to endovascular thrombectomy at the same time without waiting for the response to lysis
    • +1Door-to-needle target under 60 minutes
    • +1BP below 180/105 mmHg for 24 hours after lysis, and no intensive lowering below 140 mmHg after recanalization
    • +1No antiplatelet/anticoagulant for 24 hours, restarting after a follow-up CT
    • +1If neurologic status worsens, stops the alteplase infusion if still running and gets an emergency CT
    • -3Delays treatment to obtain CT perfusion or MRI before thrombolysis
    • -2Gives aspirin before or within 24 hours after thrombolysis without a specific indication (such as a rescue stent)
    Show answer

    Reference answer She is eligible for both IV thrombolysis and thrombectomy, so treat with both. (1) Give IV thrombolysis immediately without waiting for CT perfusion or MRI: alteplase 0.9 mg/kg (54 mg here; 5.4 mg as a bolus over 1 minute and the rest over 60 minutes) or tenecteplase 0.25 mg/kg as a single bolus (15 mg here, maximum 25 mg). Door-to-needle target under 60 minutes. (2) Activate the thrombectomy team at the same time; thrombolysis must not delay transfer for thrombectomy, and there is no need to wait to see whether lysis works. Use the standard dose, not 0.6 mg/kg low-dose alteplase. (3) BP ≤185/110 mmHg before thrombolysis and below 180/105 mmHg during and for 24 hours after; after successful recanalization do not lower systolic BP intensively below 140 mmHg (harmful). (4) No antiplatelet or anticoagulant drugs for 24 hours after thrombolysis; start them after a 24-hour CT shows no hemorrhage. Neuro checks every 15 minutes during the infusion and for 2 hours after, every 30 minutes for the next 6 hours, then hourly to 24 hours. (5) If headache, vomiting or neurologic worsening develops, stop the alteplase infusion (tenecteplase is a single bolus), get an emergency CT, and if hemorrhage is confirmed treat as symptomatic post-thrombolysis hemorrhage (cryoprecipitate, tranexamic acid, neurosurgery consult). Watch for orolingual angioedema.

    Source 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke; 2019 AHA/ASA Guidelines for the Early Management of Patients With Acute Ischemic Stroke; TNKase (tenecteplase) US prescribing information for acute ischemic stroke (2025)

  19. SE-023Short answerNeurologyAdvanced

    A 70-year-old man is 40 minutes into an IV alteplase infusion for acute ischemic stroke when he reports a severe headache and vomits; his NIHSS rises from 10 to 18 and BP is 192/104 mmHg. Describe the management steps.

    Rubric

    • +3Stops the alteplase infusion immediately
    • +2Emergency head CT
    • +2Sends fibrinogen, coagulation tests and CBC, and crossmatches
    • +2Gives cryoprecipitate (or tranexamic acid/aminocaproic acid)
    • +2Lowers BP (below 180/105 during the evaluation, then about 140 systolic once ICH is confirmed, avoiding <130)
    • +2Provides airway, ICP, temperature and glucose support, and consults neurosurgery or hematology (1 point each)
    • -3Waits to observe symptoms before stopping, or completes the infusion
    • -2Uses vitamin K or protamine as reversal
    Show answer

    Reference answer Symptomatic intracranial hemorrhage after thrombolysis is highly likely. (1) Stop the alteplase infusion immediately and lower the BP below 180/105 mmHg. (2) Emergency non-contrast head CT; at the same time send CBC, PT/INR, aPTT, fibrinogen and type and crossmatch. (3) If hemorrhage is confirmed: cryoprecipitate 10 units IV over 10-30 minutes (give more if fibrinogen remains below 150-200 mg/dL), or tranexamic acid 1 g IV over 10 minutes (or aminocaproic acid) as an alternative. (4) Once hemorrhage is confirmed, manage BP as for ICH (systolic about 140 mmHg, avoiding values below 130 mmHg) and avoid large fluctuations. The same steps apply after tenecteplase, except that it is a single bolus. (5) Neurosurgery and hematology consultation; consider surgery. (6) Supportive care: airway, intracranial pressure, temperature and glucose. Do not continue the thrombolytic, and do not give vitamin K or protamine (ineffective).

    Source 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke; 2019 AHA/ASA Guidelines (management of symptomatic intracranial bleeding after IV alteplase); 2022 AHA/ASA Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage

  20. SE-024Short answerNeurologyAdvanced

    A 52-year-old man has a complete right MCA occlusion and missed the reperfusion window. About 30 hours after onset he becomes drowsy; he has a dense left hemiplegia, and CT shows hypodensity of the entire right MCA territory with 7 mm of leftward midline shift. Outline the key management.

    Rubric

    • +3Recommends decompressive hemicraniectomy within 48 hours in a patient aged 60 or younger
    • +2Tells the family that surgery reduces death but may leave disability
    • +2Osmotic therapy (mannitol/hypertonic saline) as a bridge
    • +1Head-of-bed elevation, airway protection and temperature/glucose management
    • +1Urgent neurosurgery consult, neuro-ICU care and close monitoring of consciousness and pupils
    • -3Uses corticosteroids for ischemic cerebral edema
    Show answer

    Reference answer This is a malignant MCA infarction with declining consciousness and midline shift in a patient aged 60 or younger. Decompressive hemicraniectomy within 48 hours of onset is guideline-supported (reasonable in AHA/ASA guidance) and reduces mortality. Discuss with the family before surgery: surgery reduces death, but many survivors are left with moderate to severe disability. While awaiting surgery: head of bed at 30 degrees, avoid hypotonic fluids, osmotic therapy (mannitol or hypertonic saline) as a bridge, intubate to protect the airway if needed; keep normothermia, normoglycemia and adequate BP (do not over-lower it); monitor pupils and level of consciousness closely. Corticosteroids are not effective for ischemic cerebral edema and are not recommended; brief moderate hyperventilation (PaCO₂ 30-34 mmHg) is only a temporizing measure before surgery. Urgent neurosurgery consultation and transfer to a neurocritical care unit.

    Source 2019 AHA/ASA Guidelines for the Early Management of Patients With Acute Ischemic Stroke (decompressive craniectomy for malignant MCA infarction); 2014 AHA/ASA Scientific Statement on management of cerebral and cerebellar infarction with swelling; DECIMAL, DESTINY, HAMLET pooled analysis (Lancet Neurol 2007)

  21. SE-025Short answerNeurologyIntermediate

    A 66-year-old man with hypertension and diabetes had left-sided weakness and slurred speech last night, 10 hours ago, lasting 50 minutes and then resolving completely. His neurologic exam is now normal and BP is 158/92 mmHg. Describe the TIA risk assessment, workup and treatment to start.

    Rubric

    • +2Calculates the ABCD² score correctly (6) and identifies high risk
    • +2Brain MRI (DWI) and head and neck vessel imaging
    • +2ECG/cardiac monitoring for AF
    • +2Starts dual antiplatelet therapy within 24 hours after excluding hemorrhage (aspirin plus clopidogrel for 21 days, or ticagrelor plus aspirin for 30 days)
    • +1High-intensity statin and BP control
    • +1Revascularization within 2 weeks for severe ipsilateral carotid stenosis
    • +1Switches to anticoagulation if AF is found
    • -3Considers outpatient follow-up without evaluation because symptoms have resolved
    Show answer

    Reference answer Risk: ABCD² score (age ≥60: 1; BP ≥140/90: 1; unilateral weakness: 2; duration ≥60 min: 2, or 10-59 min: 1; diabetes: 1) = 6 here, high risk; admit or complete evaluation in a rapid TIA pathway within 24 hours (ABCD² should not be the only triage criterion; imaging and vessel findings matter more). Workup: brain MRI with DWI; head and neck vessel imaging (CTA/MRA or carotid ultrasound); ECG and at least 24 hours of cardiac monitoring for AF; CBC, coagulation, glucose/HbA1c and lipids; echocardiography as indicated. Treatment: after imaging excludes hemorrhage and with no cardioembolic source, start aspirin plus clopidogrel within 24 hours for 21 days (loading doses, e.g., aspirin 160-325 mg and clopidogrel 300-600 mg), then a single agent (ticagrelor plus aspirin for 30 days is an alternative); high-intensity statin; BP control (long term below 130/80 mmHg) and glucose control; switch to anticoagulation if AF is found; revascularize an ipsilateral 70-99% carotid stenosis within 2 weeks (50-69% individualized).

    Source 2021 AHA/ASA Guideline for the Prevention of Stroke in Patients With Stroke and TIA; 2023 AHA Scientific Statement on the emergency department evaluation and management of TIA

  22. SE-026Short answerNeurologyBasic

    In the emergency department you see a 40-year-old man (about 70 kg) with long-standing heavy alcohol use who has been in a generalized tonic-clonic seizure for more than 5 minutes. IV access is in place. List the time-ordered management of convulsive status epilepticus, including drugs and doses.

    Rubric

    • +2Stabilizes airway and vital signs and checks glucose in parallel with drug treatment
    • +2Gives empiric thiamine 100 mg IV to a patient with heavy alcohol use, without delaying dextrose for hypoglycemia
    • +2Adequate first-line benzodiazepine dose (lorazepam 0.1 mg/kg or diazepam 0.15-0.2 mg/kg, repeatable once)
    • +2Second-line levetiracetam, fosphenytoin or valproate (or phenobarbital) with the AES loading dose
    • +1For refractory SE, intubation, anesthetic infusion and continuous EEG
    • +1Searches for and treats the cause
    • -3Clearly inadequate benzodiazepine doses (e.g., repeated small diazepam doses of 2-5 mg)
    Show answer

    Reference answer Stabilization runs in parallel with drug treatment and must not delay the benzodiazepine. 0-5 minutes (stabilization): airway, oxygen, lateral position, vital signs and cardiac monitoring; fingerstick glucose; in patients with heavy alcohol use or malnutrition give thiamine 100 mg IV empirically; if glucose is below 60 mg/dL give dextrose (50 mL of D50) without delay, ideally with or just after the thiamine; draw electrolytes, CBC, renal and liver function, toxicology and antiseizure drug levels. 5-20 minutes (first line): an adequate benzodiazepine dose - lorazepam 0.1 mg/kg IV (maximum 4 mg per dose) or diazepam 0.15-0.2 mg/kg IV (maximum 10 mg per dose), repeatable once; if no IV, midazolam 10 mg IM. 20-40 minutes (second line): one full dose of levetiracetam 60 mg/kg (maximum 4500 mg), fosphenytoin 20 mg PE/kg (maximum 1500 mg PE) or valproate 40 mg/kg (maximum 3000 mg) - for 70 kg: levetiracetam 4200 mg, fosphenytoin 1400 mg PE, valproate 2800 mg; phenobarbital 15 mg/kg if none of these is available. With heavy alcohol use and possible liver disease, levetiracetam is preferred. After 40 minutes (refractory): another second-line agent, or intubation with a continuous midazolam, propofol or pentobarbital infusion and continuous EEG. Search for the cause at the same time (hypoglycemia, hyponatremia, alcohol withdrawal, intracranial lesion, infection).

    Source 2016 American Epilepsy Society Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults; ESETT trial (NEJM 2019)

  23. SE-027Short answerNeurologyIntermediate

    A 26-year-old woman with generalized epilepsy has been seizure-free for 2 years on extended-release valproate 1000 mg/day. She plans to become pregnant within a year and comes for counseling. Describe the preconception and pregnancy management of her antiseizure medication.

    Rubric

    • +3States that valproate is teratogenic and impairs neurodevelopment and should be switched before conception
    • +2Switches to levetiracetam or lamotrigine with a gradual crossover rather than abrupt withdrawal
    • +1Effective contraception during the switch
    • +1Monotherapy at the lowest effective dose
    • +1Folic acid starting before conception
    • +2Monitors levels of the new drug (especially lamotrigine) or seizure control in pregnancy and adjusts the dose
    • +1Warns against stopping medication on her own and explains the risk of seizures to mother and fetus
    • -3Advises stopping all antiseizure medication as soon as pregnancy is found
    Show answer

    Reference answer (1) Valproate is teratogenic (major malformations in about 10%, including neural tube defects in about 1-2%) and impairs neurodevelopment (lower IQ and autism risk, developmental problems in up to 30-40%); a woman planning pregnancy should be switched before conception, not after pregnancy is discovered. (2) Switch to a lower-risk drug such as levetiracetam or lamotrigine (lamotrigine can worsen myoclonic seizures, so levetiracetam is preferred if she has myoclonus): add the new drug, then taper valproate slowly once it is established; never stop abruptly. Valproate roughly doubles lamotrigine levels, so lamotrigine must be titrated slowly during the crossover and its level falls as valproate is withdrawn. Use effective contraception during the switch (estrogen-containing contraceptives lower lamotrigine levels). (3) Monotherapy at the lowest effective dose. (4) Folic acid at least 0.4 mg daily starting before conception and continued at least through the first trimester. Counsel that control may not be as good as on valproate, and try to conceive after a period (e.g., several months) of seizure freedom on the new drug. (5) Lamotrigine (and levetiracetam) clearance rises markedly in pregnancy; monitor levels or seizures and adjust the dose, and taper back to the pre-pregnancy dose over the first weeks postpartum with monitoring. (6) Detailed fetal anatomy ultrasound; most patients can breastfeed. (7) She must not stop medication on her own; generalized tonic-clonic seizures are dangerous to mother and fetus.

    Source 2024 AAN/AES/SMFM practice guideline: teratogenesis, perinatal and neurodevelopmental outcomes after in utero exposure to antiseizure medication; NICE NG217 (2022); FDA valproate boxed warning

  24. SE-028Short answerNeurologyBasic

    A 24-year-old woman had a sudden loss of consciousness at home with about 1 minute of generalized jerking, followed by 20 minutes of confusion; she bit the side of her tongue. She has never had a similar episode. In the ED she is alert with no focal deficits. Describe the tests needed in the ED and afterward, and the advice to give her at discharge.

    Rubric

    • +2Glucose and sodium
    • +2Pregnancy test (toxicology guided by history) and ECG to exclude cardiac syncope (1 point each)
    • +3EEG (1 point) and brain imaging: ED head CT plus brain MRI with an epilepsy protocol (2 points)
    • +1Explains recurrence risk and its predictors (abnormal EEG, structural lesion) and shares the treatment decision
    • +2No driving (per local law) and avoidance of high-risk activities
    • +1Teaches family seizure first aid and when to call EMS
    • -2Advises putting an object in her mouth during a seizure, or routinely loads an antiseizure medication in the ED after a single unprovoked seizure with normal findings
    Show answer

    Reference answer ED: glucose; electrolytes (sodium, calcium, magnesium), renal and liver function, CBC; pregnancy test in a woman of childbearing age; toxicology as indicated (alcohol, illicit drugs, drugs that lower the seizure threshold); ECG to exclude cardiac syncope such as long QT; head CT to exclude acute hemorrhage or a mass; lumbar puncture if febrile or meningismus. Afterward: EEG (ideally within 24-48 hours or including sleep); brain MRI with an epilepsy protocol. Distinguish a provoked from an unprovoked seizure and estimate recurrence risk (epileptiform EEG, structural lesion on MRI increase it), and decide with her about medication. Discharge advice: do not drive until cleared, following local law on the seizure-free interval (including any physician reporting duty); avoid swimming alone, heights and dangerous machinery; regular sleep, avoid sleep deprivation and alcohol; teach family to place her on her side during a seizure, put nothing in her mouth, and call EMS if it lasts more than 5 minutes; neurology follow-up.

    Source 2015 AAN/AES Evidence-based guideline: management of an unprovoked first seizure in adults; 2014 ACEP Clinical Policy: critical issues in the evaluation and management of adult patients presenting to the ED with seizures

  25. SE-029Multiple choiceNeurologyIntermediate

    A 74-year-old man had a 30-minute episode of right hand weakness and expressive aphasia 3 days ago, now resolved; his exam is normal. MRI shows a small left frontal DWI lesion. Carotid duplex and CTA show an 80% stenosis of the proximal left internal carotid artery; the right side is normal. He is on aspirin, clopidogrel and a high-intensity statin, and his surgical risk is average. Which management is most appropriate?

    1. AContinue medical therapy alone; revascularization is reserved for recurrent events
    2. BCarotid endarterectomy, ideally within 2 weeks of the event
    3. CWait 6 weeks for the infarct to stabilize, then carotid endarterectomy
    4. DCarotid artery stenting is preferred over endarterectomy at his age
    5. ESwitch to warfarin with an INR goal of 2.0-3.0
    Show answer

    Answer B

    Source 2021 AHA/ASA Guideline for the Prevention of Stroke in Patients With Stroke and TIA (timing and choice of carotid revascularization); 2021 SVS clinical practice guidelines for extracranial cerebrovascular disease

  26. SE-030Multiple choiceNeurologyAdvanced

    A 68-year-old man on phenytoin 300 mg daily for focal epilepsy is admitted with pneumonia and has one brief focal seizure. Albumin 2.0 g/dL, normal renal function, no other interacting drugs. Total phenytoin level is 8 mcg/mL (usual total range 10-20 mcg/mL). What is the most appropriate interpretation and action?

    1. AThe level is subtherapeutic; give fosphenytoin 10 mg PE/kg and increase the daily dose
    2. BThe level is subtherapeutic; increase phenytoin to 400 mg daily
    3. CCorrected for albumin, the level is about 12-16 mcg/mL (within range); measure a free phenytoin level before changing the dose
    4. DThe low level proves nonadherence; switch to levetiracetam
    5. EHypoalbuminemia lowers free phenytoin, so the patient is underdosed and needs a loading dose
    Show answer

    Answer C

    Source Dilantin (phenytoin) US prescribing information (protein binding and free phenytoin monitoring in hypoalbuminemia); Sheiner-Tozer albumin correction

  27. SE-031Multiple choiceNeurologyIntermediate

    A 22-year-old woman has focal epilepsy well controlled on carbamazepine 400 mg twice daily. She is sexually active, wants highly effective contraception and has no other medical conditions. Per the 2024 US MEC, which option is most appropriate?

    1. ACombined oral contraceptive containing 30 mcg ethinyl estradiol
    2. BProgestin-only pill (norethindrone 0.35 mg)
    3. CLevonorgestrel intrauterine device
    4. DCombined contraceptive vaginal ring
    5. EContraceptive patch
    Show answer

    Answer C

    Source 2024 US Medical Eligibility Criteria for Contraceptive Use (CDC; enzyme-inducing anticonvulsants); Tegretol (carbamazepine) US prescribing information

  28. SE-032Multiple choiceNeurologyAdvanced

    A 34-year-old woman with generalized epilepsy has breakthrough seizures on valproate 500 mg twice daily (level 75 mcg/mL). Lamotrigine is to be added while valproate is continued; she takes no enzyme inducers or estrogen. According to the US prescribing information, what is the correct starting regimen?

    1. ALamotrigine 50 mg daily for 2 weeks, then 100 mg daily
    2. BLamotrigine 25 mg daily for 2 weeks, then 50 mg daily
    3. CLamotrigine 25 mg every other day for 2 weeks, then 25 mg daily for 2 weeks
    4. DLamotrigine 100 mg twice daily from the start, because valproate does not interact with it
    5. ELamotrigine 50 mg twice daily for 2 weeks, then 100 mg twice daily
    Show answer

    Answer C

    Source Lamictal (lamotrigine) US prescribing information (escalation regimen with valproate; boxed warning for serious rash)

Report